首页> 外文会议>Joint Conference on Chemistry >In silico identification of potent inhibitors of heat shoek protein 90(Hsp90)from Indonesian natural product compounds as a novel approach to treat ebola virus disease
【24h】

In silico identification of potent inhibitors of heat shoek protein 90(Hsp90)from Indonesian natural product compounds as a novel approach to treat ebola virus disease

机译:从印度尼西亚天然产物化合物中硅质鉴定热沙蛋白90(HSP90)的有效抑制剂作为一种治疗埃博拉病毒疾病的新方法

获取原文

摘要

Heat shock protein 90(Hsp90)is a 90-kDa molecular chaperone that has various biological functions,varying from cell cycle progression to the protein folding,that is crucial for the cancer cell development.Furthermore,the activity of Hsp90 is also essential for the replication of negative-stranded viruses as the host factor,including Ebola virus(EBOV),a virus from Filoviridae family which is responsible for causing Ebola virus disease(EVD)outbreak in Africa in 2014.Thus,the inhibition of Hsp90 can be considered as the novel approach to combat EVD.In this research,we deployed an Indonesian natural products database to perform in silico ADME-Tox screening test and a series of molecular docking simulations against the Hsp90.A total of 3,429 ligands that have been docked,about thirteen ligands have outstanding pharmacological properties,and higher binding affinity in the binding site of Hsp90 than four referred standard ligands.In the end,we conclude that l-O-galloyl-6-O-luteoyl-α-D-glucose,euphorbianin and scutellarein 7-neohesperidoside as the best Indonesian natural product compound to inhibit Hsp90,suggesting a potential candidate to treat EVD effectively.
机译:热休克蛋白90(Hsp90的)是具有多种生物学功能,从细胞周期进展的蛋白质折叠,即对于癌细胞development.Furthermore关键变化的一个90-kDa的分子伴侣,Hsp90的活性也是必不可少的负链病毒作为宿主因子,包括埃博拉病毒(EBOV),丝状病毒科从科的病毒,其负责在2014.Thus在非洲引起埃博拉病毒病(EVD)爆发复制,Hsp90的抑制可以被认为是在新的方法来打击EVD.In这项研究中,我们部署了一个印度尼西亚的天然产物数据库ADME计算机-TOX进行筛选试验等一系列针对Hsp90.A共有3429种配体已对接分子对接模拟的,关于十三的配体具有出色的药理学性质,并且在Hsp90的多于四个的结合位点的结合亲和力更高称为标准ligands.In最后,我们得出结论,10-没食子酰基6-O- luteoyl-α-d葡萄糖,euphorbianin和黄芩素-7-新橙皮糖苷作为最佳印度尼西亚天然产物化合物对抑制Hsp90,显示一个潜在的候选治疗有效EVD。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号